Quality standard

Quality statements

Quality statements

Statement 1 Adults at high risk of type 2 diabetes are offered a referral to the NHS Diabetes Prevention Programme. [2016, updated 2023]

Statement 2 Adults with type 2 diabetes are offered a structured education programme at diagnosis. [2011, updated 2023]

Statement 3 Adults with type 2 diabetes who have multiple daily insulin injections and a condition or disability that means they cannot use capillary blood glucose monitoring are offered continuous glucose monitoring (CGM) to support self-monitoring. [new 2023]

Statement 4 Adults with insulin-treated type 2 diabetes having their blood glucose monitored by a care worker or healthcare professional are offered CGM. [new 2023]

Statement 5 Adults with type 2 diabetes are offered an SGLT2 inhibitor if they would benefit because of co-existing chronic heart failure, cardiovascular disease or chronic kidney disease. [new 2023]

Statement 6 Adults with type 2 diabetes have 9 key care processes completed every 12 months. [new 2023]

Statement 7 Adults with type 2 diabetes admitted to hospital have an assessment of their risk of developing a diabetic foot problem. [new 2023]

In 2023 this quality standard was updated, and statements prioritised in 2011 and 2016 were updated [2011, updated 2023] or [2016, updated 2023] or replaced [new 2023]. For more information, see update information.

The previous version of the quality standard for diabetes in adults is available as a pdf.